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M A J O R A R T I C L E
Understanding the Determinants of
Antimicrobial Prescribing Within Hospitals:
The Role of “Prescribing Etiquette”
E. Charani,1 E. Castro-Sanchez,1 N. Sevdalis,2,3 Y. Kyratsis,1 L. Drumright,1 N. Shah,1 and A. Holmes1
1The National Centre for Infection Prevention and Management, Hammersmith Hospital; and 2Department of Surgery and Cancer, and 3Imperial Centre
for Patient Safety and Service Quality, St Mary’s Hospital, Imperial College London, United Kingdom
Background. There is limited knowledge of the key determinants of antimicrobial prescribing behavior (APB)
in hospitals. An understanding of these determinants is required for the successful design, adoption, and implemen-
tation of quality improvement interventions in antimicrobial stewardship programs.
Methods. Qualitative semistructured interviews were conducted with doctors (n = 10), pharmacists (n = 10),
and nurses and midwives (n = 19) in 4 hospitals in London. Interviews were conducted until thematic saturation
was reached. Thematic analysis was applied to the data to identify the key determinants of antimicrobial prescribing
behaviors.
Results. The APB of healthcare professionals is governed by a set of cultural rules. Antimicrobial prescribing is
performed in an environment where the behavior of clinical leaders or seniors inﬂuences practice of junior doctors.
Senior doctors consider themselves exempt from following policy and practice within a culture of perceived autono-
mous decision making that relies more on personal knowledge and experience than formal policy. Prescribers iden-
tify with the clinical groups in which they work and adjust their APB according to the prevailing practice within
these groups. A culture of “noninterference” in the antimicrobial prescribing practice of peers prevents intervention
into prescribing of colleagues. These sets of cultural rules demonstrate the existence of a “prescribing etiquette,”
which dominates the APB of healthcare professionals. Prescribing etiquette creates an environment in which profes-
sional hierarchy and clinical groups act as key determinants of APB.
Conclusions. To inﬂuence the antimicrobial prescribing of individual healthcare professionals, interventions
need to address prescribing etiquette and use clinical leadership within existing clinical groups to inﬂuence practice.
Keywords. prescribing etiquette; antimicrobial prescribing; prescribing behavior.
Antimicrobial usage in acute care is widely reported to
be suboptimal [1]. Suboptimal use of antimicrobials is a
major contributing factor to emergence of multidrug-
resistant pathogens and healthcare-acquired infections [2].
To address the growing concern of emergent multi-
drug-resistant pathogens and waning supply of active
antimicrobial agents, governments and healthcare insti-
tutions continue to produce policy and practice-based
interventions [3, 4]. The aim of these policies and inter-
ventions is to optimize antimicrobial prescribing be-
haviors [4–6] and promote quality improvement.
However, these policies and interventions often fail to
consider the social and behavioral determinants of
antimicrobial prescribing [7, 8] and the multiple fac-
tors that can inﬂuence the clinical decision-making
process [9,10].This isdespite researchboth fromprimary
care [11–14] and secondary care [7, 14–21] that shows
that antimicrobial prescribing behaviors are inﬂuenced
by psychosocial determinants (attitudes, social norms,
and beliefs). Healthcare institutions often focus their
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efforts primarily on junior doctors, failing to recognize that
doctors and other healthcare professionals work within complex
clinical groups and specialties that inﬂuence their behav-
iors [22]. In particular, antimicrobial prescribing occurs within
the context of a wide social network with multiple “agents”
who continuously interact, including doctors, nurses, pharma-
cists, patients, and carers [21–24]. Lack of engagement with this
broader group of agents may fail to account for what truly in-
ﬂuences prescribing practices and, more importantly, fails to
deliver interventions that optimize prescribing behaviors [7].
To optimize antimicrobial prescribing behavior of healthcare
professionals, it is necessary to understand what appears to
work for whom and when [25]. When designing and imple-
menting quality improvement interventions (including antimi-
crobial usage) in any healthcare setting, engagement with
multidisciplinary staff and inclusion of local practice and
knowledge has been shown to facilitate implementation and
compliance [26–30]. Applying this approach to quality im-
provement interventions in antimicrobial stewardship pro-
grams requires research into the social determinants of
antimicrobial prescribing to understand how to design inter-
ventions that are implemented and adopted by healthcare pro-
fessionals and successfully inﬂuence behaviors [22, 31].
The study reported here investigated the social determinants
of antimicrobial prescribing in the hospital setting and adds to
the existing knowledge in this ﬁeld. To date, there have been
only a few qualitative studies investigating antimicrobial pre-
scribing in hospitals [7, 8]. The present study aimed to identify
(1) attitudes and perspectives of healthcare professionals on an-
timicrobial prescribing; (2) barriers to and facilitators of adher-
ence to quality improvement interventions in antimicrobial
prescribing; and (3) determinants of antimicrobial prescribing
behaviors including contextual, environmental, and social
factors.
METHODS
Setting
This study was conducted in 4 hospitals of the Imperial College
Healthcare National Health Service Trust (ICHNT), across
West London, United Kingdom. ICHNT is a multisite, 1500-
bed healthcare delivery organization that operates in partner-
ship with Imperial College London. All the hospitals within the
ICHNT operate within one organizational structure. There is a
mature antimicrobial stewardship program delivered through a
multidisciplinary team including antimicrobial pharmacists, re-
search pharmacists, infection control teams, and infectious
disease and medical microbiology teams. Measures of antimi-
crobial stewardship quality are embedded within the key per-
formance indicators of the organization, and multimodal,
cross-professional interventions are used to deliver the key ob-
jectives of the stewardship strategy [32, 33].
Inclusion and Exclusion Criteria
To be eligible for the study, participants had to be healthcare
professionals (deﬁned as doctors, pharmacists, nurses, and
midwives) with regular contact with patients and/or actively
prescribing antimicrobials.
Sampling and Recruitment
Hospital databases provided by the hospitals’ human resources
departments were analyzed and clinical staff were stratiﬁed by
profession, hospital site, and seniority (as deﬁned by job title).
Two researchers (R.E., E.C.) sent out electronic study recruit-
ment invitations in December 2010, with a 2-week reminder
follow-up email. Participants were recruited until data satura-
tion was achieved.
Qualitative Semistructured Interview Methodology
Between December 2010 and July 2011, 80 healthcare profes-
sionals were invited to participate in the study. Of these, 39 (10
doctors, 10 pharmacists, 18 nurses, 1 midwife) agreed to partic-
ipate and were interviewed face-to-face using a semistructured
interview guide. In this article, the term doctors refers to both
physicians and surgeons. In the United Kingdom, doctors
undergo a training program that includes 2 years of foundation
training ( junior doctors) and 6 years of specialist training
before they qualify to become senior doctors—consultants and
surgeons (see Supplementary Data for further information). To
ensure content and face validity, the interview guide was de-
signed through a systematic review of the literature on determi-
nants of antimicrobial prescribing behaviors previously carried
out by our group [7]. As per standard qualitative interview
practice [34], in addition to the key questions, each interview
guide included a series of supplementary questions to steer the
interview (Table 1).
The purpose of the study was described to all participants
and a consent form completed prior to interview. The majority
of the interviews were conducted by 2 experienced researchers
in hospital pharmacy and clinical nursing with qualitative re-
search expertise (E.C., R.E.). Four additional researchers were
recruited to the study (O.B., J.D., L.D., S.F.) and helped conduct
the interviews. The interviews took place in the participants’
workplace either during working hours where consent from
line managers was given or in participants’ own time. Partici-
pants who carried out the interview in their own time received
a £50 incentive with the choice to accept the cash incentive or
recommend it as a donation to charity. All interviews were
audio recorded and transcribed verbatim. Interviews lasted on
average 45 minutes each (range, 17 minutes to 1 hour 45
minutes). Participants were recruited and interviews conducted
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until saturation of themes was reached. Approval from a
National Health Service Research Ethics Committee was ob-
tained prior to data collection. Participants were coded using
numbers and the interview data anonymized using this coding
system.
Analysis
Following standard practice in qualitative data analysis [34, 35],
a deductive and inductive approach was used in analyzing the
data. Open coding was used to identify relevant concepts in the
data and group them into categories, seeking evidence of what
could constitute inﬂuences on antimicrobial prescribing behav-
iors. The inductive themes were compared with relevant
themes from a systematic review of the literature on determi-
nants of antimicrobial prescribing behaviors (this also in-
formed our interview guide) [7] and were used to develop and
reﬁne a series of ﬁrst-order codes that formed the thematic
framework. Examples of the ﬁrst-order codes used include
“role of policy as a facilitator/barrier to practice,” “positioning
of self in hierarchy,” and “role deﬁnition in antimicrobial pre-
scribing.” Three researchers (E.C., E.C.S., N. Shah) then used
this framework to analyze the data independently. All the data
were analyzed line-by-line for themes to surface until a clear
sense of the relationships among the themes emerged. This
process continued until additional analyses did not provide
further insight into the relationships between the themes. The
relationships that were corroborated by multiple informants
were kept and recorded as ﬁndings. The data structure is pre-
sented in Table 2, highlighting the themes from which the in-
ferences were developed. To ensure reliability in the coding and
analysis of the data and prevent dilution of the analysis by pre-
speciﬁed conceptual models, the researchers participated in
weekly meetings to explore the data in the transcripts and the
emerging themes. To ensure robustness of ﬁndings, all 3 re-
searchers read all the interviews and any ideas about emerging
themes were discussed in detail until a consensus was reached.
All researchers agreed to the ﬁnal major themes.
RESULTS
The staff interviewed represented a wide range of specialties
and expertise (Supplementary Data). The analysis identiﬁed 3
key themes in relation to antimicrobial prescribing behaviors:
(1) decision-making autonomy, (2) the limitations of evidence-
based policies, and (3) a culture of hierarchy (Table 2). A cross-
cutting determinant and source of tension that emerged under
each of these themes was the existence of a set of unwritten but
widely accepted cultural rules around prescribing and the
Table 1. Interview Guide, Including Supplementary Questions
Role of antibiotic prescribing in infection
control
Knowledge of antibiotic prescribing
guidelines
What aspects of antibiotic prescribing and management are you involved in?
• Prescribing? Monitoring? Restricting? Administering?
• Are you aware of any specific standards associated with antibiotic prescribing
and management?
• Are you aware of any Imperial Trust policy on antibiotic prescribing and
management?
• Do you think antibiotic prescribing has potential to put patients at risk of
infection? If so, how?
Barriers to compliance with antibiotic
prescribing guidelines
Potential facilitators to compliance with
antibiotic prescribing guidelines
Is it easy or difficult to adhere to Trust policy on antibiotic prescribing and
management? Why?
• To what extent do you have confidence in the current antibiotic policy?
• Do you feel you have had sufficient education and training on antibiotic
prescribing and management?
Do your colleagues comply with the policy?
• Do you feel you are in a position to question the antibiotic prescribing/
management behavior of your colleagues and superiors?
• Howwould your attitude differ depending on type of colleague (senior, junior,
trainees)?
• Who, in your view, is responsible for making sure that the prescribing and
management of antibiotics is optimal?
• How clear do you think it is, within your department, where responsibilities lie?
What barriers do you personally face when optimizing your prescribing and
monitoring practices?
• What would facilitate you to optimize antibiotic prescribing?
• What do you think could be done on an organizational level to improve antibiotic
prescribing and management?
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Table 2. Verbatim Quotes From Interview Transcripts to Illustrate and Validate the Themes That Emerged
Theme
Quote Relevant
to Theme
Quote in the Theme Relevant
to Prescribing Etiquette
Decision-making
autonomy
Q1 Very occasionally if I have a very strong feeling about the
patient deteriorating, despite not any other markers
suggesting of infection, I would definitely push my case
[with infection specialists] to start antibiotics or make
changes.—Senior Doctor, Pediatric Intensive Care (10 y)
Q4 I think doctor to doctor, it’s very difficult for
clinician to clinician, especially different
specialties to go and criticize one another. I think
that’s not collegial practice, so people don’t want
to do that.—Nurse, Outpatient Parenteral
Antimicrobial Therapy Services (14 y)
Q2 Sometimes during a procedure, if the surgeon feels
there’s a need to introduce antibiotics, they say so and I
have never challenged that, no one has ever challenged
that.—Nurse, Orthopedics (12 y)
Q5 . . . they [doctors] may have more information
that I’m not yet aware of which may then mean
that actually it is entirely appropriate.—
Pharmacist, Medicines for the Elderly (4 y)
Q3 Sometimes you come on the ward round and you realize
that something’s prescribed which you don’t really
understand. Not to say that your colleague’s done
something wrong but I always try and understand why
that step’s been taken. Whether there’s something that I
have missed or I have overlooked which is why this
person’s prescribed a different drug.—Senior Doctor,
Pediatric Intensive Care (10 y)
Q6 Even if they’re [visiting doctors] doing the wrong
thing, which they do do sometimes, the intensive
care consultant probably knows about it. So it’s
difficult for me to go and say you can’t do
this . . .—Pharmacist, Intensive Care Unit (7 y)
Limitations of local
evidence–based
policies
Q7 There’s no evidence base looking specifically at the
immunosuppressed end-stage renal failure population.
But my anecdotal experience is that they get sick very
quickly and so for that reason I think for each individual
patient it’s a good antibiotic the long-term consequences
of that, there’s no evidence really to say . . . but I’m fully
aware of the risks.—Specialist trainee Doctor, Renal
Medicine (7 y)
Q11 But in reality you wouldn’t, just because you
have to get on with your senior colleagues and all
your colleagues really. And so a more direct
approach such as that, I just wouldn’t—I would
never question a consultant.—Junior Doctor,
Accident and Emergency (2 y)
Q8 . . . you’ve got patients who don’t actually fit in the
guidelines and that’s when it becomes difficult because
you’ve got different consultants and different doctors
willing to try different treatments, they have different
opinions and then they kind of go with what they want,
even if you refer them to infectious diseases they don’t
take things on board . . .—Pharmacist, General Medicine
Training (2 y)
Q12 If I want to change something and I think it’s
appropriate that we just switch this as per policy,
I might go straight to the registrar for example
and find the time to, for them to get it changed.
Rather than maybe the more junior doctor who
may be reluctant because actually the consultant
mentioned it on the ward round that they actually
wanted a particular drug.—Pharmacist, Medicine
for the Elderly (4 y)
Q9 Sometimes it is difficult to . . . use the policy because
the policy will be your average sort of thing, it’s not looking
at someone at the top or at the bottom.—Pharmacist,
General Medicine (2 y)
Q13 I think that the current policy is rational. The
decision was made by a subgroup within my
specialty, composed of people whose judgment I
respect and chaired by people whose judgment I
respect and I’m very happy to comply with the
decisions that they make.—Senior Doctor, Renal
Medicine (32 y)
Q10 I think everyone I work with and personally we’re
acutely aware of the issues of antibiotic resistance and
that we do prescribe lots of broad-spectrum antibiotics.
And we’re aware of the implications of that . . . But it’s
that balance and there’s unfortunately no real evidence
base in our specific population with regards to what the
best way forwards is.—Specialist Trainee Doctor, Renal
Medicine (7 y)
Q14 I find sometimes doctors don’t think
sometimes that they need a policy to tell them
what to prescribe. And that can make it difficult.
Pharmacist, Medicines for the Elderly (4 y)
So I find that when you explain the rationale for prescribing
something and not the other, then you are listened to
more.—Pharmacist, General Medicine (5 y)
Q15 . . .the problem is that different consultants
would use different antibiotics.—Nurse, Vascular
Surgery (8 y)
You can tell like some consultants are just not interested in
what [patients are] on whereas some consultants will ask
if they’re on antibiotics. So it varies a lot between
consultants, I think if they all start feeding it down it will
work.—Pharmacist, General Medicine (5 y)
I was very aware that I needed to stick to the guidelines
because I’m quite likely to overstep them if I was left to
my devices. And it’s very variable. Some of the
consultants in general medicine were quite pedantic
about making sure that you stuck to the guidelines.—
Specialist Trainee Doctor, Renal Medicine (7 y)
The junior doctors tend to change it and the junior
doctors won’t change it if their senior doctors, if
the consultant or registrar’s specifically asked
them to prescribe something else, in which case
you can normally work out why and sometimes
it’s just that the reg wasn’t sure of what to give,
he’s just said oh use this when they could have
used something from the policy and get them to
change it or you’ll get cases where their specific
consultants or regs want to use certain things
that are outside policy.—Pharmacist, Intensive
Care Unit (7 y)
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signiﬁcant inﬂuence of these rules on healthcare professionals’
behaviors. This set of unwritten rules, or “prescribing eti-
quette,” dictates not only the prescribing behavior of doctors
but also how other healthcare professionals (ie, pharmacists
and nurses) view and exert inﬂuence on the antimicrobial pre-
scribing, administration, and monitoring processes. In the sec-
tions that follow, each of these 3 themes is presented in detail.
The cross-cutting theme of “prescribing etiquette” is discussed
in relation to each of the 3 main themes. To illustrate and vali-
date each theme, selected relevant verbatim quotes are provid-
ed in the text, with additional quotes provided in Table 2. The
number of years the participants have been qualiﬁed in their
profession at the time of the interviews is provided in paren-
theses after their specialty.
Table 2 continued.
Theme
Quote Relevant
to Theme
Quote in the Theme Relevant
to Prescribing Etiquette
Culture of hierarchy Q16 The junior doctors tend to change it and the junior
doctors won’t change it if their senior doctors, if the
consultant or registrar’s specifically asked them to
prescribe something else . . .—Pharmacist, Intensive
Care Unit (7 y)
Q19 The prescribing sometimes is very difficult
because it’s basically the junior doctor who does
the prescribing and there is quite a lot of place for
error because they take advice from us and they
sometimes even ask how do you spell the drug.
So they are prescribing something they have no
idea about. I might be doing the prescription
course next year, that would help because I could
then take direct advice from the microbiologist
and just do it myself, rather than phoning
somebody else and getting a third person to
prescribe.—Nurse, Intensive Care Unit (21 y)
Q17 That [micro ward rounds] was led by our lead clinician
who felt very strongly about it and he met a like-minded
microbiologist who also felt very strongly about it so they
led on that and got that started. And now it’s in our
culture.—Nurse, Intensive Care Unit (19 y)
Q20 I think the nurses have a big influence, they say
“oh no, we haven’t got that in stock but we’ve
got this, this is what we normally use.”—
Pharmacist, Neonatal Medicine (40 y)
Q18 Visiting consultants, they’ll comewith their team, an
entourage of people with them. Obviously therefore
they’re role modelling to their team. So if they’ve got bad
practice and it’s not challenged then it’s actually absorbed
by all the people that are standing behind themwho are
consultants of the future. So you really do need to
challenge.—Nurse, Intensive Care Unit (19 y)
Q21 I mean I think the junior doctors actually are
sometimes quite glad to see us because they
often want advice on what to dowith . . . how
to prescribe certain drugs because they often
don’t know, especially the brand-new qualified
doctors . . .—Pharmacist, Respiratory
Medicine (18 y)
Yeah I would but I would probably challenge it at a higher
level, ie, I would probably go back to our consultants and
say one of the registrars has got a habit of just putting
everybody on this and when I’ve talked to them about it
doesn’t seem to have any particular rationale except when
they worked somewhere else that’s what they did and I’m
a bit concerned.—Nurse, Intensive Care Unit (19 y)
Q22 Because my experience of working on the
wards here is that as a doctor you are very busy
and you don’t necessarily have time to do
everything, so it is very useful to have other
people who can ratify things, and they
[pharmacists] do make valuable contributions and
they are very good at kind of flagging up issues,
particularly in terms of the escalation and
stepping down and rationalizing when the time is
right, making sure that kind of empirical
prescriptions, broad spectrums aren’t left for
days and days at a time.—Specialist Trainee
Doctor, Renal Medicine (7 years)
The consultants rarely, they rarely prescribe for inpatients
themselves because they’ll always have a team of doctors
with them so they’ll make a suggestion on the ward round
but it will be a junior doctor writing the drug out . . .—
Pharmacist, Respiratory Medicine (18 y)
I think it goes from the top down so everybody has
to do the same thing. If the consultant or registrar
doesn’t set a good example, the junior will
certainly not follow it.—Specialist Trainee
Doctor, Stroke (11 y)
To be honest I don’t go round checking the drug chart of 10
patients on the ward, to see they’re on the right drugs.
There isn’t enough time in the day. I rely that people are
sensible, that are following guidelines, that the pharmacist
has checked them, the middle ranking doctor’s checking
them. Whilst it’s my responsibility the patient has the right
treatment, I don’t have the time to check every detail of it.
So I don’t, to be honest I assumemy patients are on the
right treatment, I can’t tell you they are, I haven’t seen
their drug charts.—Senior Doctor, Oncology (25 y)
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Decision-Making Autonomy
Senior doctors rely on their own professional judgment and the
need to freely choose what they judge to be the most appropri-
ate when prescribing antimicrobial prophylaxis or treatment
(Table 2, Q1 and Q2). This may involve making antimicrobial
prescribing decisions that overrule infection specialist advice
(Table 2, Q1). This assumption to exercise clinical decision-
making autonomy leads to their practice being rarely ques-
tioned by others:
. . . and then there are consultants that just do what they
want and they’re known and like all the pharmacists know
that oh that doctor’s just going to do what he wants so
that’s quite difﬁcult, you can’t really do much about that,
when it actually comes down to it. . . . —Pharmacist, In-
tensive Care Unit (7 years)
There is a clear shared view of “noninterference” when it comes
to doctors judging or intervening in the antimicrobial prescrib-
ing behavior of their colleagues:
I think you have to . . . build a working relationship with
various teams . . . Once you get to know them, and they
you, they begin to listen. But if you go onto the wards once
a month and say: do this, do that, they won’t necessarily
do that.—Senior Doctor, Medical Microbiologist (19 years)
This concept of “noninterference in prescriptions written
by others” is one that is understood by all healthcare profes-
sionals (Table 2, Q3–5). Perceived decision-making autonomy
affects how and when nonmedical healthcare professionals
choose to intervene in the antimicrobial prescribing process
(Table 2, Q6).
The social environment in which the prescribing process
occurs is heavily inﬂuenced by the behavior of senior doctors
within their different specialties. The quotes here illustrate the
importance of the impact of senior doctors, other than infec-
tion specialists, on the antimicrobial prescribing decision
process. There exists a social network within which antimicro-
bial prescribing decisions are made, and healthcare profession-
als report awareness of the need to work within this network in
their specialties. The rule of “noninterference with the clinical
decisions of others,” despite the existence of local policies
guiding antimicrobial prescribing, is an example of the inﬂu-
ence of this social network on behaviors.
Limitations of Evidence-Based Policies
Doctors rely on their own clinical knowledge and experience to
guide their antimicrobial prescribing practice and frequently
consider their patients to be “outside” the boundaries of local
evidence-based treatment policies for infection. They use anec-
dotal experience to justify their clinical decisions for individual
patients, and this can be seen as a continuum of exercising
decision-making autonomy. This attitude comes to the fore in
the different specialties where policies are considered to be for
the “average” patient and therefore seldom adhered to (Table 2,
Q7–9). In this context, patients are referred to as “special” or
atypical cases that require interventions different to that pre-
scribed by local policy. There is a clear sense of afﬁliation of
healthcare professionals to clinical groups and specialties in
which they work: that is, the local social network within spe-
cialties acts as a strong determinant of antimicrobial prescrib-
ing behaviors. Outside of their own autonomous decision
making, healthcare professionals are happy to comply with
practice that is a marker of their clinical group or identiﬁed
social network (Table 2, Q10). Senior doctors are conditioned
to exert independent thought and to exercise clinical judgment,
and they report policies to be counter to this autonomous
process:
I’m a clinician and have some degree of independent prac-
tice; protocols are quite constrictive and restrictive for in-
dividual patient use. So I don’t feel that their protocols are
necessary in my practice to guide me, but deﬁnitely for
people that are working on the ward such as nursing stuff,
protocols are good. —Specialist Trainee Doctor, Orthope-
dics
Senior doctors will overrule policy as they consider it subordi-
nate to their knowledge and clinical experience that is gained
over their years of practice—this pattern only gets reversed if
the policies have the clear endorsement of senior peers within
their own clinical groups. This is indicative of the role of hierar-
chy in inﬂuencing practice (Table 2, Q11–13).
The limitations of policy and the role of autonomous deci-
sion making in antimicrobial prescribing are also recognized by
nurses and pharmacists (Table 2, Q14 and Q15):
. . . anything you try to force upon people doesn’t go
down well, especially with doctors. If you tell them that
this is the rule, they’re certainly not going to adhere to
that. —Nurse, Outpatient Parenteral Antibiotic Therapy
Services (14 years)
A Culture of Hierarchy
The practice of prescribing is primarily performed by junior
doctors at the coalface, but it is the seniors who decide what
needs to be prescribed:
We’ll do a ward round with either the registrar, plus
or minus the consultant and see all the patients. . . . jobs
[eg, prescribing] will be allocated down to the junior
doctors . . .—Specialist Trainee Doctor, Stroke (11 years)
Although the organizational approach focuses on junior
doctors in the implementation of antimicrobial policy, local
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practice is driven by senior doctors who act as role models for
the junior staff. It is this local practice of seniors and not policy
that is emulated and sets the culture within the specialties and
clinical groups (Table 2, Q16–18). Within the context of hierar-
chy and autonomous decision making, there may be a limited
tacit inﬂuence on prescribing behaviors of doctors from nurses
and pharmacists (Table 2, Q19–22). This inﬂuence may be
transient, only limited to the behaviors of the more junior
doctors, and only valid in situations where there is no conﬂict
with the opinion or direction of senior medical staff, in which
case the latter prevails:
Consultants. Those are the people who we listen to. It’s
partly because we know the hierarchy, from the doctor’s
side of things. —Junior Doctor, Accident and Emergency
(2 years)
DISCUSSION
This study shows that in the case of antimicrobial prescribing,
prescribing etiquette is a key determinant of behavior, with pre-
scribing decisions inﬂuenced not only by clinical and therapeu-
tic goals but also by a host of cultural determinants and clinical
groups across different specialties. The principles of prescribing
etiquette are clearly understood by all healthcare professionals
(Table 3). The majority of participants described an under-
standing of the prevailing culture and etiquette of prescribing,
including those who stated lack of awareness of the existence of
speciﬁc formal hospital policies or interventions. This demon-
strates the strength of local practice and culture as a key deter-
minant of clinical behavior. Healthcare professionals are
reluctant to question the prescribing habit of their peers. In the
case of antimicrobials, prescribing etiquette and its role as a key
determinant of prescribing behaviors is highly signiﬁcant.
These ﬁndings have clear implications for quality improve-
ment interventions in the area of antimicrobial prescribing.
The unwanted consequence of emergence of antimicrobial
resistance and the need for conservation of the remaining
drugs, as well as the safe and effective treatment and prophylax-
is of infection, are key drivers of quality improvement inter-
ventions in antimicrobial stewardship. Understanding and
addressing the determinants of antimicrobial prescribing be-
haviors therefore hold the key to successful quality improve-
ment interventions. The majority of efforts undertaken to
inﬂuence antimicrobial prescribing behaviors, including policy
and interventions, target junior doctors, primarily because they
are the workforce that undertake prescribing in acute care.
However, the ability of the junior clinical team for undertaking
such tasks is limited [13, 14, 35, 36], and there is a dichotomy
between the organizational expectation from juniors to follow
ofﬁcial policy and the social and contextual norm of adhering
to “prescribing etiquette” set by one’s senior colleagues in their
clinical groups, as the evidence in this study suggests.
Because of their exposure to different clinical specialties and
greater movement across them, junior doctors can facilitate orga-
nizational coherence in antimicrobial prescribing initiatives if
supported by senior colleagues. In contrast, however, interven-
tions targeting junior doctors are likely to be ineffective if they
are expected to exhibit behaviors that run against the local pre-
scribing etiquette endorsed by their seniors. In this context, the
leadership role of seniors in the prescribing process needs to be
fostered by organizations adopting a culture that recognizes the
inﬂuence of clinical hierarchy and the perceived autonomous de-
cision-making process. Peer approval is one of the essential rules
in the successful implementation of interventions [30, 37–39].
Whereas nurses and pharmacists reported a reliance on policy to
help promote compliance of junior doctors to evidence-based
practice, doctors reported adhering to policy only if it was en-
dorsed by peers from their own specialties and clinical groups.
The reported acceptance of noncompliance of senior staff
with local policy is another element of prescribing etiquette.
This noncompliance is justiﬁed ﬁrst by recognition of the expe-
rience and expertise of senior staff and second, by a broader
deﬁnition of “evidence base,” which includes personal experi-
ence of individuals and the perception that polices are for the
“average” cases. Personal experience/expertise seems to win
over evidence-based policies and guidelines.
To optimize antimicrobial practice, organizations need to
engage more broadly outside infectious disease and microbio-
logy specialties and have an open dialogue with their senior
colleagues across the different specialties with regard to antimi-
crobial prescribing behaviors. Quality improvement interven-
tions in antimicrobial prescribing must aim to understand
prevailing practice, and the only way to do that is to engage
with senior doctors from different specialties. Both the local
and national cultural inﬂuences on antimicrobial prescribing
should be incorporated into local policy and practice by
involving local opinion and expertise and recognizing the key
Table 3. Rules of Antimicrobial Prescribing Etiquette
1. Noninterference with the prescribing decisions of colleagues:
reluctance to interfere with the prescribing decisions of
colleagues. In the case of antimicrobial prescribing, there is a
reluctance to intercept antimicrobial prescriptions started by
colleagues. This recognizes the autonomous decision-making
process of prescribing.
2. Accepted noncompliance to policy: Deviations from policy
recommendations are tolerated and put in the context of the
prescriber’s experience and expertise and the specific clinical
scenario. This leads to hierarchy and expertise, and not policy as
determinants of prescribing practice behaviors.
3. Hierarchy of prescribing: Prescribing as an activity is performed by
junior doctors. But it is the senior doctors who decidewhat is
prescribed.
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inﬂuencing agents within existing clinical groups and the
potential role of social networks. To go further, quality im-
provement interventions in antimicrobial prescribing can aim
to build elements of prescribing etiquette into the decision ar-
chitecture (eg, in the redesign of medication charts) to intro-
duce dedicated sections for antimicrobials [40] and positively
reinforce best practice via leadership at local level within clini-
cal groups.
The main limitation of this study was that it was conducted
in 4 teaching hospitals, with reliance on self-reporting. This
study could be replicated more widely in different institutions
and could be further supplemented with a survey based on the
themes we found here (to achieve larger-scale generalization).
CONCLUSIONS
This study broadens the scope of research on prescribing be-
haviors and extends our understanding of how to optimize
them by describing the social context of prescribing and the in-
ﬂuence of prescribing etiquette on antimicrobial practice in
hospitals. The impact of prescribing etiquette on the behavior
of healthcare professionals must be recognized and addressed
in the antimicrobial stewardship agenda. Leadership within ex-
isting social networks and clinical groups needs to be harnessed
for the delivery of quality improvement in antimicrobial stew-
ardship.
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